Our pipeline includes four product candidates that target multiple malignacies.

Meet our experienced leadership team and renowned investors.

Latest news, updates and media communications from  CBT Pharmaceutials, Inc.

About Us

CBT Pharmaceuticals is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.

The company was founded in 2016 as a spin-off of Crown Bioscience International with headquarters in California.

Read more.